Cluster of Differentiation 163
EmergingCD163 is a macrophage activation marker studied as a complementary test for hyperinflammatory syndromes and liver disease.
CD163 marks a specific type of activated immune cell (macrophages). Its blood-soluble form is being studied as an additional clue, alongside several other markers, to help doctors recognize dangerous immune overactivation conditions and chronic liver disease.
CD163 is a scavenger receptor expressed on monocytes and macrophages, particularly anti-inflammatory (M2) macrophages; its soluble form reflects macrophage activation.
Soluble CD163 rises in conditions involving macrophage activation, including hemophagocytic lymphohistiocytosis/macrophage activation syndrome and chronic liver disease, and is being studied as a complementary marker alongside ferritin and the interferon-driven cytokines discussed elsewhere in this set.
Measured via serum immunoassay; it's used primarily in research settings and select specialized centers rather than as a universally standardized clinical test, reflecting its status as part of an evolving, still-developing diagnostic panel for hyperinflammatory syndromes.
Elevated soluble CD163 alongside other markers (ferritin, soluble CD25, cytokine panel) can help distinguish hyperinflammatory syndromes like HLH/MAS from sepsis or other conditions with overlapping presentations, informing the threshold for aggressive immunosuppressive treatment.
Part of an evolving, still-developing diagnostic panel rather than a universally standardized clinical test at this time.
- General hematology/hepatology reference literature on soluble CD163 in macrophage activation syndromes and liver disease.